The global market for biosynthetic materials—polymers and chemicals derived from biological feedstocks via fermentation or catalytic conversion—is at a critical tipping point. Valued at approximately USD 120.16 billion in 2026, the sector is projected to reach USD 249.36 billion by 2034, growing at a robust CAGR of 9.6%. While demand is surging, the “pricing problem” remains: these materials currently command a 20% to 100% price premium over their fossil-based incumbents. The “Innovation” Capital Load: Early-stage biosynthetic plants often have higher specific capital costs than massive, fully depreciated petrochemical complexes. Pro-Tip for Buyers: Treat biosynthetic materials as a dynamic cost target.